Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions by Ambrosis, Nicolás Martín et al.
ORIGINAL RESEARCH
published: 04 February 2021
doi: 10.3389/fmed.2021.640688
Frontiers in Medicine | www.frontiersin.org 1 February 2021 | Volume 8 | Article 640688
Edited by:
Chaminda Jayampath Seneviratne,
National Dental Centre of
Singapore, Singapore
Reviewed by:
Imad Omar Al Kassaa,
Lebanese University, Lebanon
Liliane Okdah,







This article was submitted to
Infectious Diseases - Surveillance,
Prevention and Treatment,
a section of the journal
Frontiers in Medicine
Received: 11 December 2020
Accepted: 11 January 2021
Published: 04 February 2021
Citation:
Ambrosis N, Martin Aispuro P,
Belhart K, Bottero D, Crisp RL,
Dansey MV, Gabrielli M, Filevich O,
Genoud V, Giordano A, Lin MC,
Lodeiro A, Marceca F, Pregi N,
Lenicov FR, Rocha-Viegas L, Rudi E,
Solovey G, Zurita E, Pecci A,
Etchenique R and Hozbor D (2021)












Communities Inhabiting Closed or
Semi-closed Institutions
Nicolás Ambrosis 1, Pablo Martin Aispuro 1, Keila Belhart 1, Daniela Bottero 1,
Renée Leonor Crisp 2, María Virginia Dansey 2,3, Magali Gabrielli 1, Oscar Filevich 4,
Valeria Genoud 2, Alejandra Giordano 1, Min Chih Lin 2,5, Anibal Lodeiro 1,6,
Felipe Marceca 2,7, Nicolás Pregi 2,8, Federico Remes Lenicov 9, Luciana Rocha-Viegas 2,10,
Erika Rudi 1, Guillermo Solovey 2,5, Eugenia Zurita 1, Adali Pecci 2,10, Roberto Etchenique 2,11
and Daniela Hozbor 1*
1 Laboratorio VacSal, Facultad de Ciencias Exactas, Instituto de Biotecnología y Biología Molecular, Universidad Nacional de
La Plata y CCT La Plata-CONICET, La Plata, Argentina, 2Universidad de Buenos Aires, Facultad de Ciencias Exactas y
Naturales, Departamento de Química Biológica, Buenos Aires, Argentina, 3Universidad de Buenos Aires, Facultad de
Ciencias Exactas y Naturales, Unidad de Microanálisis y Métodos Físicos en Química Orgánica, CONICET, Buenos Aires,
Argentina, 4 Escuela de Ciencia y Tecnología de la Universidad Nacional de San Martín, CONICET, Buenos Aires, Argentina,
5Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Instituto del Cálculo, CONICET, Buenos Aires,
Argentina, 6 Laboratorio de Genética, Facultad de Ciencias Agrarias y Forestales, Universidad Nacional de La Plata, La Plata,
Argentina, 7Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Matemática, Instituto
de Investigaciones Matemáticas “Luis Santaló”, CONICET, Buenos Aires, Argentina, 8Universidad de Buenos Aires, Facultad
de Ciencias Exactas y Naturales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales, CONICET,
Buenos Aires, Argentina, 9Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA,
CONICET, Buenos Aires, Argentina, 10Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Instituto de
Fisiología, Biología Molecular y Neurociencias, CONICET, Buenos Aires, Argentina, 11Universidad de Buenos Aires, Facultad
de Ciencias Exactas y Naturales, Departamento de Química Inorgánica, Analítica y Química Física, Instituto de Química Física
de los Materiales, Medio Ambiente y Energía, CONICET, Buenos Aires, Argentina
Background: The high COVID-19 dissemination rate demands active surveillance
to identify asymptomatic, presymptomatic, and oligosymptomatic (APO)
SARS-CoV-2-infected individuals. This is of special importance in communities
inhabiting closed or semi-closed institutions such as residential care homes, prisons,
neuropsychiatric hospitals, etc., where risk people are in close contact. Thus, a pooling
approach—where samples are mixed and tested as single pools—is an attractive
strategy to rapidly detect APO-infected in these epidemiological scenarios.
Materials and Methods: This study was done at different pandemic periods
between May 28 and August 31 2020 in 153 closed or semi-closed institutions
in the Province of Buenos Aires (Argentina). We setup pooling strategy in two
stages: first a pool-testing followed by selective individual-testing according to pool
results. Samples included in negative pools were presumed as negative, while
samples from positive pools were re-tested individually for positives identification.
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Results: Sensitivity in 5-sample or 10-sample pools was adequate since only 2 Ct values
were increased with regard to single tests on average. Concordance between 5-sample
or 10-sample pools and individual-testing was 100% in the Ct ≤ 36. We tested 4,936
APO clinical samples in 822 pools, requiring 86–50% fewer tests in low-to-moderate
prevalence settings compared to individual testing.
Conclusions: By this strategy we detected three COVID-19 outbreaks at early stages
in these institutions, helping to their containment and increasing the likelihood of saving
lives in such places where risk groups are concentrated.
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INTRODUCTION
COVID-19, caused by SARS-CoV-2, emerged on December
12, 2019 with 27 cases in Wuhan, China, and spread rapidly,
surpassing 45 million infected people and one million deaths
all over the world in October 2020. Its symptomatology
was classified in six groups that might correlate with illness
severity (1, 2). Elderly, and those with underlying medical
conditions are at higher risk of developing serious illness.
Meanwhile, others can become infected and develop moderate
symptoms or even carry the infection asymptomatically. Such
asymptomatic, presymptomatic, and oligosymptomatic (APO)
people represent a great concern for health system since they may
go unnoticed while contributing to SARS-CoV-2 circulation (3–
5). In addition, APOs cannot be detected by passive surveillance,
which diagnoses only suspicious cases.
Mitigating SARS-CoV-2 circulation necessitates continuous
tracking, detection, and isolation of cases, for which active
surveillance with massive and opportune APO detection
methods is required. A possible strategy may be pooling
individual samples for molecular diagnosis. This strategy, which
was used successfully for syphilis, HIV, HBV, HCV, Chlamydia
trachomatis and Neisseria gonorrhoeae (6–13), consists of mixing
several samples together and then test the pooled samples in
one reaction. If the pool test is negative, it may be presumed
that all patients are negative, while if it is positive, each sample
is separately tested to find out which is responsible for that
result. Thus, fewer tests are run overall, saving time and testing
supplies, allowing faster return of results in most cases. As
expected, when prevalence is low, pooling is usually cost-saving
regarding testing samples individually. Using certain algorithms
(i.e., dividing positive pools into halves, testing each of the two
new smaller pools and continue subdividing positive pools, or
2 two-dimensional array with master pool testing etc.), 60–80%
savings were calculated (14–16).
SARS-CoV-2 was isolated and described (17, 18)
enabling molecular-diagnosis, which is performed mostly
by retrotranscribed quantitative PCR (RT-qPCR) (19). With
this technique, the pooling-strategy was assayed with different
algorithms, particularly in asymptomatics, since low prevalence
is expected there. By implementing the linear eight-sample
Dorfman clustering to test 26,576 samples from asymptomatic
individuals, 31 (0.12%) SARS-CoV-2 positives were identified,
thus achieving a 7.3-fold increase in throughput (20). Moreover,
by using a Shiny application (https://www.chrisbilder.com/
shiny), efficiency of the pool size was assessed (21).
Special concern exists for SARS-CoV-2 dissemination in
closed or semi-closed institutions such as residential care homes,
neuropsychiatric hospitals, prison houses, police stations housing
prisoners, etc. because they are inhabited by people in close
contact that, in addition, have one or more risk factors. If the
disease gets access to these vulnerable high-density communities,
the demands for hospitalization, complex treatments, and
assisted breathing could suddenly increase. To cope with this risk,
in this study we implemented an active surveillance through a
pooling-strategy aimed at early APOs detection in closed or semi-
closed institutions in the Province of Buenos Aires, Argentina
(population: 17.5 million, 38.5% of Argentina population) at
differentmoments of the pandemic. The study is part of the active
surveillance carried out by the Ministry of Health of the Province
of Buenos Aires, and complements the passive surveillance that
is being performed from the beginning of the pandemic.
MATERIALS AND METHODS
Sample Collection
Swabs (Britania or any rayon or dacron swab approved by the
Argentine regulatory body) from both nostrils and the throat
were collected by healthcare providers, and placed immediately
into a sterile transport tube containing 2–3ml of either viral
transport medium, Amies transport medium, phosphate buffered
saline, or sterile saline. For processing, all samples were properly
labeled with the patient’s filiation data and accompanied by their
corresponding notification forms. Samples thus conditioned
were shipped to the VacSal laboratory in refrigerated safety
containers, and stored at 2–8◦C for a maximum of 3 days, after
which they were processed and analyzed.
RNA Extraction From Individual and Pooled
Samples
Sample inactivation and RNA extraction were done using
certified class-II biological safety cabinet. RNA was extracted
from five-sample and 10-sample pools, as well as from individual
samples, using the same RNA extraction kit (RNA Mini Kit
Genaid RT300, Geneaid Biotech Ltd) following manufacturer’s
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instructions. Briefly, 200 µl of individual or pooled samples
in viral transport media were used for RNA extraction. The
individual samples, as well as the pools, were included in the same
extraction batch, and the same aliquot was used. Negative pools
with 3, 5, or 10 negative samples were included in the assays.
Retrotranscribed Quantitative PCR
(RT-qPCR) for SARS-CoV-2 RdRp, E,
ORF1ab, and N Genes
Single-step RT-qPCR for SARS-CoV-2 targeting the RdRp, E
and N genes (GeneFinderTM COVID-19 PLUS RealAmp Kit)
and ORF1ab and N genes (DisCoVery SARS-CoV-2RT-PCR
Detection Kit Rox) was performed on the extracted RNA from
individual and pooled samples immediately after RNA extraction.
To assess the sensitivity of the pooling strategy, we arbitrarily
chose positive RNA samples with different Ct previously
quantified, to prepare ad hoc diluted mixes with negative RNA
samples. RT-qPCR was performed according to the procedure
for individual samples in the clinical laboratory, with identical
thermocycler and program (Applied Biosystems R© 7500 fast), and
with reagents used at the VacSal and Facultad de Ciencias Exactas
y Naturales labs. Reaction mixtures using GeneFinder kit were
heated to 50◦C 20min for reverse transcription, denatured at
95◦C 10min, and then 50 cycles of amplification were carried
out at 95◦C 15 s and 58◦C 60 s. Fluorescence was measured
using the FAM (for RdRp gene), Texas Red (for E gene), JOE
(ABI)/VIC (CFX96) (for N gene), and Cy5 (for internal control)
channels. Reaction mixtures using DisCoVery kit were heated to
50◦C 10min for reverse transcription, denatured at 95◦C 30 s,
and then 45 cycles of amplification were carried out at 95◦C 5 s
and 58◦C 34 s. Fluorescence was measured using the FAM (for
ORF1ab gene), VIC (CFX96) (for N gene), and Rox (for internal
control) channels.
Concordance between individual and pooled sample testings
was calculated, and expressed in percentages.
Determination of the Limit of Detection
The limit of detection for the pooling method was assessed
following the protocol already described (22). The test
material was RNA obtained from anonymous SARS-CoV-2
negatives and positives, which were collected at Instituto de
Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS). First
four independent positive RNA extracts with Ct ranging 31–34
were analyzed in 10 replicates of 1:20 pools. Then, one positive
RNA sample (Ct 31.7) was analyzed in 20 replicates of different
pool sizes (1, 10, 20, 40, 80, and 160). Negative RNAs were used
for dilution. RT-qPCRs were performed as described above. The
limit of detection for RT-qPCR methods was estimated from
analysis of replicate standard curves.
Surveillance in Semi-closed Institutions
This strategy was implemented since the end of May 2020
as part of surveillance activities coordinated by the Ministry
FIGURE 1 | Scheme of the two pooling strategies used in this work. (A) square matrix array. Here the samples are grouped in pools 1–5 representing rows, and in
pools A–E representing columns. If pools 2 and C are positive, it is concluded that the third sample of pool 2, which is also the second sample of pool C, is positive
(+). The result of this sample is confirmed by an individual test. (B) linear array. Here the positive pool (in this case, pool 2) must be opened to identify the positive
sample (+).
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of Health of the Province of Buenos Aires following national




consent for these diagnostic activities (Public Health activities)
is not requested. The VacSal laboratory was chosen to validate
and carry out the pool strategy based on the clinical samples
obtained from the residents or healthcare workers from closed
or semi-closed institutions. At the beginning of the pandemic
and when the prevalence of COVID-19 cases was low, sample
groupings were performed using a square matrix array (columns
and rows). To this end, sample groupings were done in two
ways: on the one hand, a group of samples represented a
row of the matrix and on the other hand, the samples were
grouped again to represent a column of the matrix (Figure 1A).
Thus, if only one row and one column tested positive, the
positive sample could be identified within the pools (Figure 1A).
When the prevalence of COVID-19 cases increased (after
June) or when it was unknown, we used the linear grouping
array. In this case, if all pools gave negative results in the
RT-qPCR, the experimentation was concluded. In contrast,
if a positive result was obtained for a pool of samples, then
each sample that is included in the pool was tested individually
(Figure 1B).
In a 3-month period, 4,936 clinical samples from 153
institutions distributed in 29 municipalities of the Province of
Buenos Aires were evaluated.
RESULTS AND DISCUSSION
Evaluation of Pooling Performance
From 526 independent anonymous SARS-CoV-2 positive RNAs
stored at−70◦C for setup studies, 20 representative samples were
systematically chosen. Samples were ordered in an equispaced
manner by initially measured Ct as depicted in Figure 2,
alongside a second measurement of them after being defrozen,
and the respective 1:20 pools prepared from original samples.
To determine the probability of detection near the
positive/negative detection boundary, 10 replicates of samples
#17 to #20, which possessed the lowest Cts, were analyzed
in 1:20 pools. Figure 3A indicates that pools belonging to
the samples with original Ct 32.4 and 33.3 were detected
at 100% rate, while samples with Ct 34.0 and 35.1 were
detected at 70 and 50% rate, respectively. To determine the
suitability of the pooling method for a range of dilutions, a
study was conducted by comparing 20 replicates of different
dilution pools, previously known to be near the edge of
the detected/undetected result for ORF1ab and N genes.
The result indicated a high rate of detection in pools <1:20
(Figure 3B).
From the comparison of detection probability and the
complete clinical samples Ct histogram, the pool method
robustness may be estimated. Figure 4A shows the histogram
of all 526 samples ordered by N gene-Ct. Despite samples
corresponded to initial diagnostic tests, a bimodal distribution is
apparent. This two-peak histogram was as previously reported
FIGURE 2 | Comparison of RT-qPCR detection of selected samples alone or
in pools, and assessment of stability after freezing and thawing. Twenty
representative samples with a range of Ct values were subjected to RT-qPCR
alone or diluted in 1:20 with negative samples and measured. After dilution, 18
of the 20 samples were detected, while two samples, which possessed the
highest Ct values, were not. Red diamonds: Ct values of the samples
measured alone (N gene, GeneFinder kit). Pink circles: Ct values of the 1:20
pool. In parallel, Ct values for the same samples measured alone were
obtained after freezing and thawing to observe their stability (blue squares).
These last two measures were from N gene performed with DisCoVery kit. The
average 1Ct value due to the dilution for the measurements at the same run
was 4.95, close to the theoretical value (4.3).
for SARS-Cov-2 infection (23), although, to our knowledge,
no explanation was provided yet. Preliminary results indicate
that the bimodality is unrelated with symptoms severity, since
asymptomatic individuals also present similar histograms. Cts
corresponding to high and low viral loads are rather evenly
distributed along samples. The line indicates the probability
of positive detection of a single sample in a 20-samples pool.
Figure 4B shows detectable and undetectable samples in the
histogram. The coincidence value is 95.3%. It is important
to note that the 5% that is lost is not evenly distributed
among the samples but corresponds to the lowest specimens’
viral loads.
Assessment of Pooling Strategy Sensitivity
The impact of pooling clinical samples aliquots (nasopharyngeal-
swabs) prior RNA extraction was tested. To this end, clinical
samples with Cts in the ranges of either 20–23 or 30–33 were
employed. By combining these samples with negative clinical
samples, 1:5 and 1:10 pools were formed. From them, RNA
was extracted and RT-qPCR was performed to obtain the Cts.
Regardless of individual Ct of the positive RNA extract included
in the pool, Cts increased 1.9 ± 1.1 units in 1:5 pools with
respect to individual RNA extract, and 2.2 ± 0.3 units in 1:10
pools. Regarding clinical samples whose individual RNA extracts
possessed Ct≥ 36, they turned out negative when pooled together
with four or more negative samples.
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FIGURE 3 | Probability of detection of samples included in pools of different sizes. Samples #17 to #20, which possessed the highest Ct values, were diluted 1:20
with negative samples and measured. (A) Diamonds: Original Ct (ORF1) from samples #17 to #20. Circles: Ct values from 10 replicates of the same samples diluted
1:20 with negative samples and measured. Detection with Ct < 40 was positive in all dilutions of samples #17 and #18, 7 out of 10 dilutions of sample #19, and 5 out
of 10 dilutions of sample #20 (circles with the same Ct value appear superimposed). (B) Probability of detection, as determined in 20 replicas as before, for pools
containing one positive sample of Ct = 31.7 (ORF1) diluted at 1:10 to 1:160 with negative samples. Blue squares: ORF1 gene. Green circles: N gene. Lines are best
fits of sensitivity curves.
FIGURE 4 | Robustness of the pool method. (A) Histogram of the 526 initial diagnostic samples and probability of their individual detection in a 20 samples pool in
experiments performed as depicted in Figures 2, 3. (B) The same histogram indicating the fraction of samples that will be not detected in a 20 samples pool (red
bars).
Frontiers in Medicine | www.frontiersin.org 5 February 2021 | Volume 8 | Article 640688
Ambrosis et al. Active Surveillance of SARS-CoV-2 Infection
Pooling Strategy Applied to Active
Surveillance of COVID-19 in Closed or
Semi-closed Facilities in the Province of
Buenos Aires, Argentina
On the basis of these results and considering that contagiousness
of individuals with Ct ≥ 36 would not impact on COVID-19
epidemiology (24–26), the Ministry of Health of the Province of
Buenos Aires decided to apply thismethodology to analyze health
situation in closed or semi-closed facilities.
The first confirmed case in the Province of Buenos Aires was
detected on March 8, 5 days later than the first case detected in
Argentina. From this date on, the rate of increase in the week
average of total number of cases (N) as well as in the daily
reported cases (n) was fast until the end of May, although few
cases were still reported. The pooling-strategy was started onMay
28, when a significant increase was evident, and data presented
here are until August 31. From the slope of plots of log2N against
time, N duplication time was deduced for this whole period as
16.1 days; however, N duplication time was increasing from 12.4
days between May 28 and July 7 to 29.9 days between August 18
and 31.
FromMay 28 to August 31, 4,936 samples were received from
153 institutions distributed in 29 municipalities in the Province
of Buenos Aires. Between May 28 and July 7 (duplication time
12.4 days) the prevalence of positives in the analyzed samples
did not exceed 4% (40 positives out of 1,052 clinical samples
analyzed). In these cases, the clinical samples were pooled mostly
applying a matrix clustering where samples are arranged in a
squarematrix with each row and each column tested in a different
pool (Figure 1A). Therefore, samples whose row and column
are both positive are retested individually. Notice that if there
is only one positive sample there will be only one positive row
and one positive column. In this scenario the positive sample can
be identified at this stage without additional individual testing.
So, although this strategy involves more reactions than linear
clustering when the number of samples to be tested is small,
it allows frequent positives identification without opening pools
when prevalence is low. This strategy allowed saving time and
kits (66% in average). During a second period comprised between
July 8 and August 2 (duplication time 16.9 days) the growth
rate in the number of cases was still accelerating for both n
and N values. Hence, given that higher percentage of positivity
was expected in this epidemiologic context, the advantage of
avoiding opening pools through matrix clustering was lost, so
linear clustering (Figure 1B) was implemented. Although at the
beginning of this period pools of five samples for RNA extraction
and 10 samples (two pools of five) for RT-qPCRwere used, during
most of the period analyses were done with pools of five clinical
samples for both RNA extraction and RT-qPCR. During this
second period 1,730 samples were processed, from which 481
were positive (27.8% prevalence). Finally, during August, when
duplication time raised to 22.1 days in the first fortnight, and
to 29.9 days in the second 1,262 samples were processed, with
358 positives (28.4%) in the first fortnight and 892 samples with
135 positives (15.1%) in the second Thus, the number of people
tested per kit (kit saving) ranged from 2.0 to 7.4 depending on the
place of origin, with an average of 3.0. Given the high prevalence,
this level of savings is quite better than the values predicted
by usual mathematical models. This is because pooled samples
are not independent of each other since they were obtained
from the same closed or semi-closed facility. In other words,
since positive samples are unevenly distributed among facilities,
pooling-strategy is more effective than predicted.
Because the strategy was used mostly with samples from
care homes, the majority were from elderly population. In the
group >75-year-old, 30.2% positive cases were detected (1,415
positives in 4,682 clinical samples). Furthermore, there were
44.7% positives in the group 10–14-year-old, and 42.8% in the
group 5–9-year-old, albeit from smaller samples (17 positives out
of 38 and nine out of 21, respectively). Almost all positive cases
were APO, irrespective of age. Interestingly, in asymptomatic
cases, the elder group tended to possess lower Ct than younger
groups (Figure 5A), being the lowest Cts the most frequent
among asymptomatic elders (Figure 5B).
Early Detection of Infection Foci
Tracing of infection foci and outbreaks was possible in
institutions from which samples were received repeatedly. A
first example is a women psychiatric hospital at Temperley
(Municipality of Lomas de Zamora) from which 216 samples
from 210 people distributed in different rooms—including health
workers and resident patients—were received and processed on
June 19, 23, and 30, July 3, 6, 14, 23, and 28, and August 14 and
20. Analyses were carried out in 106 reactions with a kit saving of
2.6± 2.0.
Until June 23 all samples were negative. On June 30 there
were five positives, one of which corresponded to an ambulance
driver. Therefore, samples from the other drivers and his close
family contacts were asked, all of which, as well as a nurse,
resulted positive on July 3 (seven positives). Meanwhile, the
other samples, which included 17 healthcare workers and 29
residents, were all negative. In view of this situation, isolation
procedures were launched and as result, there were no positives
20 days later. However, three new positive cases were detected on
July 28, including a nurse. Epidemiologic investigation showed
that this nurse has recently been concluded her preventive
quarantine because of being close contact of a symptomatic case.
Therefore, all patients that were in contact with this nurse were
isolated, and analyzed on August 14. It turned out that all 26
patients were positive, and 21 of them developed symptoms.
Strict isolation was undertaken, but one of the patients that had
comorbidity conditions deceased. Stringent isolation measures
were undertaken because focus dissemination to other rooms of
the hospital was detected. On the next survey, carried out August
20 among 18 asymptomatic health workers with close contact
among them, only 2 were positive.
In another example, a total of 123 samples from 105 different
people were received from a disabled center. This center has
two sieges, one at Bernal and the other at Quilmes (both in the
Municipality of Quilmes). Samples were from young patients,
withmean age 24± 4 years in Bernal and 23± 9 years inQuilmes.
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FIGURE 5 | Distribution of Ct values in the clinical samples from asymptomatic individuals. (A) Cts according to age for the 10 cohorts between ages 1 and <100
years. (B) Frequencies of Cts in the age group 70–100 years.
From Bernal, 35 samples from 28 different patients were
processed on July 16 and 21, and August 11 (kit saving: 2.0 ±
1.0). On July 16 there were 7 positives out of 15 total samples
(47%), while on July 21 all 13 samples analyzed were positive.
Therefore, isolation protocols were applied and all negatives from
July 16 were re-analyzed. In this second analysis all patients were
negative again.
In turn, 88 samples belonging to 77 different patients were
received from Quilmes, which were processed in 28 reactions
(kit saving: 3.4 ± 1.4). Eleven samples were received twice each;
consecutive analyses of these samples resulted either negative
in both instances (three cases) or negative in the first analysis
and positive in the second (eight cases). RT-qPCRs were carried
out at June 30, July 23 and 30, and August 11. On June 30, all
results were negative. The first positive was detected on July 23 in
a girl that had cardiac antecedents and presented odynophagia,
who was negative in the first analysis on June 30. Therefore,
samples were obtained from other patients and analyzed on
July 30. All these samples, which amounted 37, were positive.
At this moment, several of these patients were hospitalized
and prevention measures were further stressed. In the new
sampling carried out on August 11, positivity was reduced to
four positives detected among 11 samples (36%). Three of the
negatives observed at August 11 were previously negative on June
30, showing the control of the focus.
CONCLUSIONS
Pooling effectiveness depends on the prevalence of positive
samples (27). Therefore, batch sizes for pool testing or even the
decision of pool testing should be taken at the laboratory or
regional levels, considering positivity rates, specific groups, and
categories being tested. Groups with high pre-test probability or
serious manifestations are inadequate for pool testing.
Pooling up to 5–10 samples increased test capacity with
existing equipment and test kits and detected positives with
Cts ≤ 36 with sufficient diagnostic accuracy (2 Cts increase on
average). Remarkably, the use of this strategy in the Province of
Buenos Aires allowed early outbreaks detection, and evidenced
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that APOs may present Cts as low as those of symptomatic
individuals. The role of APOs in virus transmission must be
further studied.
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